| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Aclidinium bromide |
| Brand | Eklira Genuair® |
| Indication | For treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). (Maintenance bronchodilator) |
| Assessment Process | |
| Rapid review commissioned | 23/10/2012 |
| Rapid review completed | 26/10/2012 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |